Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.

Reduction or depletion of mitochondrial DNA (mtDNA) has been associated with cancer progression. Although imbalanced mtDNA content is known to occur in prostate cancer, differences in mtDNA content between African American (AA) and Caucasian American (CA) men are not defined. We provide the first ev...

Full description

Bibliographic Details
Main Authors: Shahriar Koochekpour, Timothy Marlowe, Keshav K Singh, Kristopher Attwood, Dhyan Chandra
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3781126?pdf=render
_version_ 1818146660628299776
author Shahriar Koochekpour
Timothy Marlowe
Keshav K Singh
Kristopher Attwood
Dhyan Chandra
author_facet Shahriar Koochekpour
Timothy Marlowe
Keshav K Singh
Kristopher Attwood
Dhyan Chandra
author_sort Shahriar Koochekpour
collection DOAJ
description Reduction or depletion of mitochondrial DNA (mtDNA) has been associated with cancer progression. Although imbalanced mtDNA content is known to occur in prostate cancer, differences in mtDNA content between African American (AA) and Caucasian American (CA) men are not defined. We provide the first evidence that tumors in AA men possess reduced level of mtDNA compared to CA men. The median tumor mtDNA content was reduced in AA men. mtDNA content was also reduced in normal prostate tissues of AA men compared to CA men, suggesting a possible predisposition to cancer in AA men. mtDNA content was also reduced in benign prostatic hyperplasia (BPH) tissue from AA men. Tumor and BPH tissues from patients ≥ 60 years of age possess reduced mtDNA content compared to patients <60 years of age. In addition, mtDNA content was higher in normal tissues from patients with malignant T3 stage disease compared to patients with T2 stage disease. mtDNA levels in matched normal prostate tissues were nearly doubled in Gleason grade of >7 compared to ≤ 7, whereas reduced mtDNA content was observed in tumors of Gleason grade >7 compared to ≤ 7. Together, our data suggest that AA men possess lower mtDNA levels in normal and tumor tissues compared to CA men, which could contribute to higher risk and more aggressive prostate cancer in AA men.
first_indexed 2024-12-11T12:22:53Z
format Article
id doaj.art-ca8185b42af349d2b92d982defd013a7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T12:22:53Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ca8185b42af349d2b92d982defd013a72022-12-22T01:07:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7468810.1371/journal.pone.0074688Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.Shahriar KoochekpourTimothy MarloweKeshav K SinghKristopher AttwoodDhyan ChandraReduction or depletion of mitochondrial DNA (mtDNA) has been associated with cancer progression. Although imbalanced mtDNA content is known to occur in prostate cancer, differences in mtDNA content between African American (AA) and Caucasian American (CA) men are not defined. We provide the first evidence that tumors in AA men possess reduced level of mtDNA compared to CA men. The median tumor mtDNA content was reduced in AA men. mtDNA content was also reduced in normal prostate tissues of AA men compared to CA men, suggesting a possible predisposition to cancer in AA men. mtDNA content was also reduced in benign prostatic hyperplasia (BPH) tissue from AA men. Tumor and BPH tissues from patients ≥ 60 years of age possess reduced mtDNA content compared to patients <60 years of age. In addition, mtDNA content was higher in normal tissues from patients with malignant T3 stage disease compared to patients with T2 stage disease. mtDNA levels in matched normal prostate tissues were nearly doubled in Gleason grade of >7 compared to ≤ 7, whereas reduced mtDNA content was observed in tumors of Gleason grade >7 compared to ≤ 7. Together, our data suggest that AA men possess lower mtDNA levels in normal and tumor tissues compared to CA men, which could contribute to higher risk and more aggressive prostate cancer in AA men.http://europepmc.org/articles/PMC3781126?pdf=render
spellingShingle Shahriar Koochekpour
Timothy Marlowe
Keshav K Singh
Kristopher Attwood
Dhyan Chandra
Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
PLoS ONE
title Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
title_full Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
title_fullStr Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
title_full_unstemmed Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
title_short Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
title_sort reduced mitochondrial dna content associates with poor prognosis of prostate cancer in african american men
url http://europepmc.org/articles/PMC3781126?pdf=render
work_keys_str_mv AT shahriarkoochekpour reducedmitochondrialdnacontentassociateswithpoorprognosisofprostatecancerinafricanamericanmen
AT timothymarlowe reducedmitochondrialdnacontentassociateswithpoorprognosisofprostatecancerinafricanamericanmen
AT keshavksingh reducedmitochondrialdnacontentassociateswithpoorprognosisofprostatecancerinafricanamericanmen
AT kristopherattwood reducedmitochondrialdnacontentassociateswithpoorprognosisofprostatecancerinafricanamericanmen
AT dhyanchandra reducedmitochondrialdnacontentassociateswithpoorprognosisofprostatecancerinafricanamericanmen